← FDA DRUG APPROVALS

FDA NDA · NDA211363

EPINEPHRINE

Sponsor: INTL MEDICATION SYS

APPLICATION
NDA211363
TYPE
NDA
ORIGINAL APPROVAL
2022-08-15
LATEST ACTION
2022-08-15
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

EPINEPHRINE · ReferencePrescription
EPINEPHRINE 1MG/10ML (0.1MG/ML) · SOLUTION · INTRAVENOUS

Approval history

2022-08-15Type 7 - Drug Already Marketed without Approved NDA · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →